Gastrointestinal inflammation and the circulating IGF system in humans

Area of Science:

• Endocrinology
• Gastroenterology
• Metabolic Research

Background:

• Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) regulate tissue growth.
• Aberrant IGF system activity is implicated in tumorigenesis.
• Gastrointestinal inflammation may disrupt normal metabolic processes.

Purpose of the Study:

• To investigate the status of the IGF system in adult patients with various gastrointestinal inflammatory conditions.
• To determine circulating concentrations of IGF-I, IGF-II, and their binding proteins (IGFBP-3, IGFBP-2, IGFBP-1).

Main Methods:

• Serum samples from 92 adult patients with gastrointestinal inflammation were analyzed.
• Radioimmunoassay (RIA) was used to measure IGF-I and IGF-II concentrations.
• Immunoblotting characterized IGFBP profiles and proteolytic patterns.

Main Results:

• Significantly lower concentrations of both IGF-I and IGF-II were observed in patients compared to healthy controls (p < 0.001).
• Immunoblotting revealed a ~60% decrease in intact IGFBP-3, with a ~1.7-fold increase in IGFBP-2 and a ~3.5-fold increase in IGFBP-1.
• No significant alterations in IGFBP fragmentation or proteolysis were detected between patients and controls.

Conclusions:

• The insulin-like growth factor system is significantly imbalanced in patients with gastrointestinal inflammation, irrespective of the underlying cause.
• These alterations in the IGF system may contribute to the metabolic consequences of inflammation.
• Understanding these changes could aid in predicting patient recovery efficiency.